Literature DB >> 22539596

Cadherin 6 has a functional role in platelet aggregation and thrombus formation.

Eimear Dunne1, Christopher M Spring, Adili Reheman, Wuxun Jin, Michael C Berndt, Debra K Newman, Peter J Newman, Heyu Ni, Dermot Kenny.   

Abstract

OBJECTIVE: Thrombosis occurs at sites of vascular injury when platelets adhere to subendothelial matrix proteins and to each other. Platelets express many surface receptor proteins, the function of several of these remains poorly characterized. Cadherin 6 is expressed on the platelet surface and contains an arginine-glycine-aspartic acid motif, suggesting that it might have a supportive role in thrombus formation. The aim of this study was to characterize the role of cadherin 6 in platelet function. METHODS AND
RESULTS: Platelet aggregation was inhibited by both antibodies and exogenous soluble cadherin 6. Platelet adhesion to immobilized cadherin 6 was inhibited by arginine-glycine-aspartic acid-serine tetrapeptides. Antibodies to α(IIb)β(3) inhibited platelet adhesion to cadherin 6. Because platelet aggregation occurs in fibrinogen and von Willebrand factor double-deficient mice, we investigated whether cadherin 6 is an alternative ligand for the integrin α(IIb)β(3). Platelet aggregation in fibrinogen and von Willebrand factor double-deficient mice was significantly inhibited by an antibody to cadherin 6. In flow-based assays, inhibition of cadherin 6 caused a marked reduction in thrombus formation in both human and mouse blood.
CONCLUSIONS: This study demonstrates the role of cadherin 6 as a novel ligand for α(IIb)β(3) and highlights its function in thrombus formation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22539596      PMCID: PMC4155514          DOI: 10.1161/ATVBAHA.112.250464

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  31 in total

Review 1.  Modulation of integrin-binding selectivity by mutation within the RGD-loop of snake venom proteins: a novel drug development approach.

Authors:  X Lu; D Lu; M F Scully; V V Kakkar
Journal:  Curr Med Chem Cardiovasc Hematol Agents       Date:  2003-06

2.  Distribution of GPlb on the in resting platelets.

Authors:  G Escoloa; J G White
Journal:  Blood       Date:  1998-12-15       Impact factor: 22.113

3.  Identification of a binding site for integrin alphaEbeta7 in the N-terminal domain of E-cadherin.

Authors:  P I Karecla; S J Green; S J Bowden; J Coadwell; P J Kilshaw
Journal:  J Biol Chem       Date:  1996-11-29       Impact factor: 5.157

4.  Arginine-glycine-aspartic acid- and fibrinogen gamma-chain carboxyterminal peptides inhibit platelet adherence to arterial subendothelium at high wall shear rates. An effect dissociable from interference with adhesive protein binding.

Authors:  J B Lawrence; W S Kramer; L P McKeown; S B Williams; H R Gralnick
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

5.  Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation.

Authors:  A Reheman; P Gross; H Yang; P Chen; D Allen; V Leytin; J Freedman; H Ni
Journal:  J Thromb Haemost       Date:  2005-02-23       Impact factor: 5.824

6.  A palmitylated peptide derived from the glycoprotein Ib beta cytoplasmic tail inhibits platelet activation.

Authors:  K Martin; G Meade; N Moran; D C Shields; D Kenny
Journal:  J Thromb Haemost       Date:  2003-12       Impact factor: 5.824

7.  Interaction of porcine von Willebrand factor with the platelet glycoproteins Ib and IIb/IIIa complex.

Authors:  F I Pareti; M Mazzucato; E Bottini; P M Mannucci
Journal:  Br J Haematol       Date:  1992-09       Impact factor: 6.998

8.  Isolation and sequence analysis of human cadherin-6 complementary DNA for the full coding sequence and its expression in human carcinoma cells.

Authors:  Y Shimoyama; M Gotoh; T Terasaki; M Kitajima; S Hirohashi
Journal:  Cancer Res       Date:  1995-05-15       Impact factor: 12.701

9.  Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.

Authors:  X Lu; J A Williams; J J Deadman; G P Salmon; V V Kakkar; J M Wilkinson; D Baruch; K S Authi; S Rahman
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

10.  Direct and regulated interaction of integrin alphaEbeta7 with E-cadherin.

Authors:  J M Higgins; D A Mandlebrot; S K Shaw; G J Russell; E A Murphy; Y T Chen; W J Nelson; C M Parker; M B Brenner
Journal:  J Cell Biol       Date:  1998-01-12       Impact factor: 10.539

View more
  22 in total

Review 1.  Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting.

Authors:  Annalisa Contursi; Angela Sacco; Rosalia Grande; Melania Dovizio; Paola Patrignani
Journal:  Cell Mol Life Sci       Date:  2017-05-09       Impact factor: 9.261

2.  Plasma fibronectin supports hemostasis and regulates thrombosis.

Authors:  Yiming Wang; Adili Reheman; Christopher M Spring; Jalil Kalantari; Alexandra H Marshall; Alisa S Wolberg; Peter L Gross; Jeffrey I Weitz; Margaret L Rand; Deane F Mosher; John Freedman; Heyu Ni
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

3.  Multi-generational genome wide association studies identify chromosomal regions associated with ascites phenotype.

Authors:  K J Tarrant; S Dey; R Kinney; N B Anthony; D D Rhoads
Journal:  Poult Sci       Date:  2017-06-01       Impact factor: 3.352

4.  An RGD motif present in cadherin 17 induces integrin activation and tumor growth.

Authors:  Rubén A Bartolomé; Alberto Peláez-García; Inmaculada Gomez; Sofía Torres; María Jesús Fernandez-Aceñero; Beatriz Escudero-Paniagua; J Ignacio Imbaud; J Ignacio Casal
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

5.  Epithelial (E)-Cadherin is a Novel Mediator of Platelet Aggregation and Clot Stability.

Authors:  Vanessa M Scanlon; Alexandra M Teixeira; Tarun Tyagi; Siying Zou; Ping-Xia Zhang; Carmen Jane Booth; M Anna Kowalska; Jialing Bao; John Hwa; Vincent Hayes; Michael S Marks; Mortimer Poncz; Diane S Krause
Journal:  Thromb Haemost       Date:  2019-03-12       Impact factor: 5.249

Review 6.  Fibronectin maintains the balance between hemostasis and thrombosis.

Authors:  Yiming Wang; Heyu Ni
Journal:  Cell Mol Life Sci       Date:  2016-04-21       Impact factor: 9.261

7.  Ferric Chloride-induced Murine Thrombosis Models.

Authors:  Wei Li; Marvin Nieman; Anirban Sen Gupta
Journal:  J Vis Exp       Date:  2016-09-05       Impact factor: 1.355

8.  In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom derived anti-thrombotic agent targeting human platelet GPIbα.

Authors:  Benjamin Xiaoyi Li; Xiangrong Dai; Xiaohong Ruby Xu; Reheman Adili; Miguel Antonio Dias Neves; Xi Lei; Chuanbin Shen; Guangheng Zhu; Yiming Wang; Hui Zhou; Yan Hou; Tiffany Ni; Yfke Pasman; Zhongqiang Yang; Fang Qian; Yanan Zhao; Yongxiang Gao; Jing Liu; Maikun Teng; Alexandra H Marshall; Eric G Cerenzia; Mandy Lokyee Li; Heyu Ni
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

Review 9.  Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies.

Authors:  Xiaohong Ruby Xu; Naadiya Carrim; Miguel Antonio Dias Neves; Thomas McKeown; Tyler W Stratton; Rodrigo Matos Pinto Coelho; Xi Lei; Pingguo Chen; Jianhua Xu; Xiangrong Dai; Benjamin Xiaoyi Li; Heyu Ni
Journal:  Thromb J       Date:  2016-10-04

10.  Platelets in hemostasis and thrombosis: Novel mechanisms of fibrinogen-independent platelet aggregation and fibronectin-mediated protein wave of hemostasis.

Authors:  Yan Hou; Naadiya Carrim; Yiming Wang; Reid C Gallant; Alexandra Marshall; Heyu Ni
Journal:  J Biomed Res       Date:  2015-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.